|Chemical Name||florbetaben F 18|
|Dosage Form||Injection (intravenous; 50 to 5000 MBq/mL (1.4 to135 mCi/mL))|
|Drug Class||Radioactive diagnostic agents|
|Company||Life Molecular Imaging|
- For positron emission tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.